Non disponible en dehors du Royaume-Uni et de l'Irlande
Analysis Note
Typical composition (per vial): Amphotericin B 5.0 mg; Cefoperazone 16.0 mg. Growth promotion test in accordance with ISO 11133. Supplement tested with base Art. 1.00070.Growth - Campylobacter coli ATCC 43478 (WDCM 00004): good - Campylobacter jejuni ATCC 33291 (WDCM 00005): good - Campylobacter jejuni ATCC 29428 (WDCM 00156): good - Staphylococcus aureus ATCC 25923 (WDCM 00034): no growth - Escherichia coli ATCC 25922 (WDCM 00013): inhibited growth - Escherichia coli ATCC 8739 (WDCM 00012): inhibited growthIncubation: 44 hrs. 41.5 °C with Anaercult C. E.coli and Staph.aur. aerobic. Strains tested with three-loop-streak.
Application
CCDA Selective Supplement is an additive used during the preparation of Campylobacter Blood Free Selective Agar for the enrichment of Campylobacter from foods.
General description
CCDA Selective Supplement is a mixture of two antibiotics (Amphotericin B & Cefoperazone) in lyophilized form. Amphotericin B largely reduces the growth of yeasts and molds, while Cefoperazone especially inhibits the growth of Enterobacteriaceae.
Linkage
Replaces: 1.00071
Packaging
10 vial in Fibre case
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :